SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for BIO KEY INTERNATIONAL INC (BKYI) (CIK 0001019034) (BKYI) — Jul 5, 2018

BIO KEY INTERNATIONAL INC (BKYI) (CIK 0001019034)
Date: July 5, 2018 · CIK: 0001019034 · Accession: 0000000000-18-020693

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-225934

Date
July 5, 2018
Author
Michael DePasquale
Form
UPLOAD
Company
BIO KEY INTERNATIONAL INC (BKYI) (CIK 0001019034)

Letter

July 5, 2018 Michael DePasquale Chief Executive Officer BIO-key International, Inc. 3349 Highway 138, Building A, Suite E Wall, New Jersey 07719 Re:BIO-key International, Inc. Registration Statement on Form S-3 Filed June 28, 2018 File No. 333-225934 Dear Mr. DePasquale: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rule 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Jeff Kauten, Attorney-Advisor, at (202) 551-3447, or in his absence, Jan Woo, Legal Branch Chief, at (202) 551-3453, with any questions. If you require further assistance, please contact Barbara C. Jacobs, Assistant Director, at (202) 551-3730. Division of Corporation Finance Office of Information Technologies and Services cc: Vincent A. Vietti

Show Raw Text
July 5, 2018
Michael DePasquale
Chief Executive Officer
BIO-key International, Inc.
3349 Highway 138, Building A, Suite E
Wall, New Jersey 07719
Re:BIO-key International, Inc.
Registration Statement on Form S-3
Filed June 28, 2018
File No. 333-225934
Dear Mr. DePasquale:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rule 461 regarding requests for acceleration.  We remind you that the
company and its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
            You may contact Jeff Kauten, Attorney-Advisor, at (202) 551-3447, or in his absence,
Jan Woo, Legal Branch Chief, at (202) 551-3453, with any questions.  If you require further
assistance, please contact Barbara C. Jacobs, Assistant Director, at (202) 551-3730.
Division of Corporation Finance
Office of Information Technologies
and Services
cc:       Vincent A. Vietti